US senators are opposing a federal appeal that would limit the use of “copay accumulators”, which prevent copay assistance from reducing patient’s out-of-pocket costs for medications. The Health and Human Services (HHS) department appealed a decision to overturn a rule allowing the use of copay accumulators mainly for brand-name medications with generic equivalents. The group of 19 senators argue that the accumulators have increased health plan profits and placed a financial burden on patients, who often go without medication due to costs.
Group-IB’s Threat Intelligence and Defence Centre Equip Undergraduates with Sophisticated Cybersecurity Technologies to Boost Threat Analysis and Enhance Cyber Resilience for Campus Start-ups
Hey there from the heart of the San Francisco Bay Area! It’s an absolute pleasure to have you back again for our chat on some
